Canbridge Pharmaceuticals (HKSE:01228) Days Inventory : 117.13 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Canbridge Pharmaceuticals Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Canbridge Pharmaceuticals's Average Total Inventories for the six months ended in Dec. 2023 was HK$15.7 Mil. Canbridge Pharmaceuticals's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$24.4 Mil. Hence, Canbridge Pharmaceuticals's Days Inventory for the six months ended in Dec. 2023 was 117.13.

The historical rank and industry rank for Canbridge Pharmaceuticals's Days Inventory or its related term are showing as below:

HKSE:01228' s Days Inventory Range Over the Past 10 Years
Min: 67.68 Med: 149.08 Max: 1047.5
Current: 121.64

During the past 5 years, Canbridge Pharmaceuticals's highest Days Inventory was 1047.50. The lowest was 67.68. And the median was 149.08.

HKSE:01228's Days Inventory is ranked better than
68.91% of 653 companies
in the Biotechnology industry
Industry Median: 192.72 vs HKSE:01228: 121.64

Canbridge Pharmaceuticals's Days Inventory increased from Dec. 2022 (103.68) to Dec. 2023 (117.13). It might indicate that Canbridge Pharmaceuticals's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Canbridge Pharmaceuticals's Inventory Turnover for the six months ended in Dec. 2023 was 1.56.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Canbridge Pharmaceuticals's Inventory-to-Revenue for the six months ended in Dec. 2023 was 0.24.

Canbridge Pharmaceuticals Days Inventory Historical Data

The historical data trend for Canbridge Pharmaceuticals's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Canbridge Pharmaceuticals Days Inventory Chart

Canbridge Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

1,047.50

67.68

206.06

149.08

88.70

Canbridge Pharmaceuticals Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Inventory	Get a 7-Day Free Trial				190.74	171.80	103.68	166.71	117.13

Competitive Comparison of Canbridge Pharmaceuticals's Days Inventory

For the Biotechnology subindustry, Canbridge Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Canbridge Pharmaceuticals's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Canbridge Pharmaceuticals's Days Inventory distribution charts can be found below:

* The bar in red indicates where Canbridge Pharmaceuticals's Days Inventory falls into.

Canbridge Pharmaceuticals Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Canbridge Pharmaceuticals's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (10.971	+	9.607)	/	2 )	/	42.337	*	365
=	10.289					/	42.337	*	365
=	88.70

Canbridge Pharmaceuticals's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (21.748	+	9.607)	/	2 )	/	24.428	*	365 / 2
=	15.6775					/	24.428	*	365 / 2
=	117.13

Canbridge Pharmaceuticals (HKSE:01228) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Canbridge Pharmaceuticals's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	24.428	/	15.6775
	=	1.56

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Canbridge Pharmaceuticals's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	15.6775	/	65.43
	=	0.24

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Canbridge Pharmaceuticals Days Inventory Related Terms

Thank you for viewing the detailed overview of Canbridge Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Canbridge Pharmaceuticals (HKSE:01228) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Canbridge Pharmaceuticals Inc (HKSE:01228) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

MF1:Germany

Address

Building 21, No. 388 Xinping Street, Unit 18, 6th Floor, Suzhou Industrial Park,, Suzhou, CHN

Website

https://www.canbridgepharma.com

Canbridge Pharmaceuticals Inc is a global biopharmaceutical company. It is committed to the research, development, and commercialization of biotech therapies targeting rare diseases and rare oncology. The company's core product in the rare oncology area CAN008, is a glycosylated CD95-Fc fusion protein being developed for the treatment of glioblastoma multiforme (GBM). In the rare disease area, the company have seven biologics and small molecules products and product candidates for the treatment of Hunter Syndrome (MPS II) and other lysosomal storage disorders (LSDs), complement mediated disorders, hemophilia A, metabolic disorders, and rare cholestatic liver diseases including ALGS, PFIC and BA. Its pipeline consists of biologics, small molecules, and gene therapy solutions and 13 drugs.

Executives

Xue James Qun	2101 Beneficial owner
Athos Capital Limited	2102 Investment manager
Moskey Matthew Love	2201 Interest of corporation controlled by you
Schulte-hillen Friedrich Bela	2201 Interest of corporation controlled by you
Athos Asia Event Driven Master Fund	2101 Beneficial owner
Ctx Pharma Holdings Limited	2101 Beneficial owner
Kolchinsky Anna Inge Leonore Haas	2202 Interest of your spouse
Kolchinsky Peter	2305 Beneficiary of a trust
Ra Capital Management, L.p.	2102 Investment manager
Ra Capital Healthcare Fund Gp, Llc	2201 Interest of corporation controlled by you
Ra Capital Healthcare Fund, L.p.	2101 Beneficial owner
Wuxi Apptec Co., Ltd.
Qiming Corporate Gp Iv, Ltd.	2201 Interest of corporation controlled by you
Qiming Gp Iv, L.p.	2201 Interest of corporation controlled by you
Qiming Venture Partners Iv, L.p.	2101 Beneficial owner

Canbridge Pharmaceuticals (HKSE:01228) Headlines

No Headlines